3 Immunopathogenesis of IBD and its connection to depression IBD is the archetype of a disease driven by a dysregulated interaction between host genetic susceptibility, environmental factors, and the gut microbiota (Craig et al., 2022
For oral semaglutide, the PIONEER 6 trial showed non-inferiority for cardiovascular safety, though it is important to note that Rybelsus does not have a specific licensed indication for cardiovascular risk reduction in the UK
doi:10.1016/j.ejim.2025.04.024 d'Entremont MA, Poorthuis MHF, Fiolet ATL, et al
Understanding Oral Semaglutide and Its Growing Demand Oral semaglutide is the tablet form of Semaglutide, a GLP-1 receptor agonist that improves glycemic control, promotes weight loss, and reduces cardiovascular risk in patients with type 2 diabetes
The Weekly Dose: Retatrutide Nasal Sprays and Drops Dave Knapp Sep 18, 2025 2 min read And Our Trip to D.C